Evidence map›Paper›PMID 18516278›Full record

ArticleSeminars in breast disease2007

Evaluating Population-Based Screening Mammography Programs Internationally.

Carrie N Klabunde, Rachel Ballard-Barbash, for the International Breast Cancer Screening Network

Abstract read
In one paragraph

Article in Seminars in breast disease, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Trial
  2. Breast Cancer Screening Interval: Effect on Rate of Late-Stage Disease at Diagnosis and Overall Survival.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Carrie N KlabundeApplied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Rachel Ballard-Barbash
for the International Breast Cancer Screening Network

Funding

Intramural NIH HHS Z99 CA999999
6 · The paper itself

Abstract

This report describes the purpose and activities of the International Breast Cancer Screening Network (IBSN), a voluntary consortium of countries that focuses on collaborative research to identify and promote efficient, effective approaches to breast cancer control world-wide through population-based screening mammography. Sponsored by the U.S. National Cancer Institute, the IBSN was established in 1988 with eleven participating countries. By 2005, membership had grown to 27 countries. Recent IBSN efforts have involved gathering information on program organization and quality assurance activities, evaluating measures and methodologies for assessing screening mammography performance and outcomes, and examining the information that programs are providing to women as a means of facilitating informed decision-making about the benefits and risks of screening mammography. The ongoing IBSN effort demonstrates that-despite marked differences in health care systems-international collaborative work can contribute new knowledge to the monitoring and evaluation of organized, population-based screening mammography programs, and identify potential areas for improvement in screening performance in practice.

Identifiers

PMID18516278
PMCPMC2390929

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.